[Heart failure in coronary heart disease]
- PMID: 8225845
[Heart failure in coronary heart disease]
Similar articles
-
[Treatment of heart failure: what--when--how?].Verh Dtsch Ges Inn Med. 1990;96:157-67. Verh Dtsch Ges Inn Med. 1990. PMID: 2092435 Review. German. No abstract available.
-
[The value of ACE inhibitors in heart failure (mechanism of action)].Z Kardiol. 1992;81 Suppl 4:85-91. Z Kardiol. 1992. PMID: 1290308 Review. German.
-
[Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].Wien Med Wochenschr. 1996;146(11):221-4. Wien Med Wochenschr. 1996. PMID: 8928518 Review. German.
-
[The ischemic heart--causes, effects and therapy].Klin Anasthesiol Intensivther. 1995;47:206-20. Klin Anasthesiol Intensivther. 1995. PMID: 7715175 Review. German. No abstract available.
-
[Pharmacologic myocardial protection during percutaneous transluminal coronary angioplasty (PTCA) by intracoronary dipyridamole: hemodynamic, contractile and dynamic ventricular consequences].Z Kardiol. 1995 Nov;84(11):898-910. Z Kardiol. 1995. PMID: 8571641 Clinical Trial. German.
Cited by
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2021 May 22;5(5):CD012721. doi: 10.1002/14651858.CD012721.pub3. Cochrane Database Syst Rev. 2021. PMID: 34022072 Free PMC article.
-
Beta-blockers and inhibitors of the renin-angiotensin aldosterone system for chronic heart failure with preserved ejection fraction.Cochrane Database Syst Rev. 2018 Jun 28;6(6):CD012721. doi: 10.1002/14651858.CD012721.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2021 May 22;5:CD012721. doi: 10.1002/14651858.CD012721.pub3. PMID: 29952095 Free PMC article. Updated.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical